U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07644247) titled 'STudy of Aspirin Removal in Patients Supported by the Fully Magnetically Levitated CH-VAD Pump' on April 21.
Brief Summary: This multi-center, prospective, randomized, double-blinded, placebo-controlled study aims to investigate whether withdrawal of aspirin from the antithrombotic regimen in patients supported with the CH-VAD pump is non-inferior to the standard antithrombotic regimen of vitamin K antagonist combined with aspirin in terms of safety and efficacy.
Study Start Date: June 25
Study Type: INTERVENTIONAL
Condition:
LVAD (Left Ventricular Assist Device) Thrombosis
LVAD
LVAD (Left Ventricular Assist Device)
LVAD-related...